{"id":16044,"date":"2023-07-19T15:16:00","date_gmt":"2023-07-19T07:16:00","guid":{"rendered":"https:\/\/flcube.com\/?p=16044"},"modified":"2024-12-01T15:27:12","modified_gmt":"2024-12-01T07:27:12","slug":"pfizer-and-flagship-pioneering-invest-100-million-in-drug-candidates-development","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=16044","title":{"rendered":"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development"},"content":{"rendered":"\n<p>Global pharmaceutical giant Pfizer (<a href=\"https:\/\/www.google.com\/finance\/quote\/PFE:NYSE\">NYSE: PFE<\/a>) and venture capital firm Flagship Pioneering have this week announced a joint commitment to invest USD 50 million each into the development of 10 drug candidates. Pfizer retains the option to acquire these candidates, while Flagship stands to collect up to USD 700 million in milestone payments and royalties. This strategic partnership aims to capitalize on the expertise within Flagship\u2019s healthcare and biotechnology portfolio.<\/p>\n\n\n\n<p><strong>Leveraging Flagship\u2019s Biotechnology Ecosystem<\/strong><br>The collaboration will draw upon the capabilities of Flagship\u2019s diverse portfolio, which includes renowned companies such as Denali Therapeutics (<a href=\"https:\/\/www.google.com\/finance\/quote\/DNLI:NASDAQ\">NASDAQ: DNLI<\/a>), Foghorn Therapeutics (<a href=\"https:\/\/www.google.com\/finance\/quote\/FHTX:NASDAQ\">NASDAQ: FHTX<\/a>), Generate Biomedicines, Inari, Indigo Agriculture, Omega Therapeutics (<a href=\"https:\/\/www.google.com\/finance\/quote\/OMGA:NASDAQ\">NASDAQ: OMGA<\/a>), Sana Biotechnology (<a href=\"https:\/\/www.google.com\/finance\/quote\/SANA:NASDAQ\">NASDAQ: SANA<\/a>), Seres Therapeutics (<a href=\"https:\/\/www.google.com\/finance\/quote\/MCRB:NASDAQ\">NASDAQ: MCRB<\/a>), Tessera Therapeutics, and notably Moderna (<a href=\"https:\/\/www.google.com\/finance\/quote\/MRNA:NASDAQ\">NASDAQ: MRNA<\/a>). Moderna, in particular, is currently entangled in a series of legal disputes with Pfizer over the intellectual property rights of the RNA technology utilized in their SARS-CoV-2 vaccines.<\/p>\n\n\n\n<p><strong>Implications for the Pharmaceutical Industry<\/strong><br>This significant investment underscores the commitment of both Pfizer and Flagship Pioneering to drive innovation in drug development. The partnership highlights the potential for synergies between large pharmaceutical companies and venture capital firms focused on biotechnology, aiming to accelerate the progression of novel drug candidates through the development pipeline.<a href=\"https:\/\/flcube.com\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Global pharmaceutical giant Pfizer (NYSE: PFE) and venture capital firm Flagship Pioneering have this week&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1522,453,203,2524,1014,1225,863,452,309,454,2523],"class_list":["post-16044","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-denali-therapeutics","tag-foghorn-therapeutics","tag-moderna","tag-nasdaq-mcrb","tag-nasdaq-mrna","tag-nasdaq-sana","tag-nyse-pfe","tag-omega-therapeutics","tag-pfizer","tag-sana-biotechnology","tag-seres-therapeutics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Global pharmaceutical giant Pfizer (NYSE: PFE) and venture capital firm Flagship Pioneering have this week announced a joint commitment to invest USD 50 million each into the development of 10 drug candidates. Pfizer retains the option to acquire these candidates, while Flagship stands to collect up to USD 700 million in milestone payments and royalties. This strategic partnership aims to capitalize on the expertise within Flagship\u2019s healthcare and biotechnology portfolio.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=16044\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=16044\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-19T07:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-01T07:27:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16044#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16044\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development\",\"datePublished\":\"2023-07-19T07:16:00+00:00\",\"dateModified\":\"2024-12-01T07:27:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16044\"},\"wordCount\":219,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Denali Therapeutics\",\"Foghorn Therapeutics\",\"Moderna\",\"NASDAQ: MCRB\",\"NASDAQ: MRNA\",\"NASDAQ: SANA\",\"NYSE: PFE\",\"Omega Therapeutics\",\"Pfizer\",\"Sana Biotechnology\",\"Seres Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=16044#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16044\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=16044\",\"name\":\"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-07-19T07:16:00+00:00\",\"dateModified\":\"2024-12-01T07:27:12+00:00\",\"description\":\"Global pharmaceutical giant Pfizer (NYSE: PFE) and venture capital firm Flagship Pioneering have this week announced a joint commitment to invest USD 50 million each into the development of 10 drug candidates. Pfizer retains the option to acquire these candidates, while Flagship stands to collect up to USD 700 million in milestone payments and royalties. This strategic partnership aims to capitalize on the expertise within Flagship\u2019s healthcare and biotechnology portfolio.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16044#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=16044\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16044#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development - Insight, China&#039;s Pharmaceutical Industry","description":"Global pharmaceutical giant Pfizer (NYSE: PFE) and venture capital firm Flagship Pioneering have this week announced a joint commitment to invest USD 50 million each into the development of 10 drug candidates. Pfizer retains the option to acquire these candidates, while Flagship stands to collect up to USD 700 million in milestone payments and royalties. This strategic partnership aims to capitalize on the expertise within Flagship\u2019s healthcare and biotechnology portfolio.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=16044","og_locale":"en_US","og_type":"article","og_title":"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=16044","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-07-19T07:16:00+00:00","article_modified_time":"2024-12-01T07:27:12+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=16044#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=16044"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development","datePublished":"2023-07-19T07:16:00+00:00","dateModified":"2024-12-01T07:27:12+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=16044"},"wordCount":219,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Denali Therapeutics","Foghorn Therapeutics","Moderna","NASDAQ: MCRB","NASDAQ: MRNA","NASDAQ: SANA","NYSE: PFE","Omega Therapeutics","Pfizer","Sana Biotechnology","Seres Therapeutics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=16044#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=16044","url":"https:\/\/flcube.com\/?p=16044","name":"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-07-19T07:16:00+00:00","dateModified":"2024-12-01T07:27:12+00:00","description":"Global pharmaceutical giant Pfizer (NYSE: PFE) and venture capital firm Flagship Pioneering have this week announced a joint commitment to invest USD 50 million each into the development of 10 drug candidates. Pfizer retains the option to acquire these candidates, while Flagship stands to collect up to USD 700 million in milestone payments and royalties. This strategic partnership aims to capitalize on the expertise within Flagship\u2019s healthcare and biotechnology portfolio.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=16044#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=16044"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=16044#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/16044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16044"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/16044\/revisions"}],"predecessor-version":[{"id":16049,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/16044\/revisions\/16049"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}